CEO @ DestiNA Genomics Ltd
Hugh Ilyine is a biomedical entrepreneur, with more than 25 years’ experience including country management for multinational corporations, as well as biotechnology companies from start-up through to public listings. His work experience has covered the fields of food and agriculture, stem cells, protein therapeutics and molecular diagnostics. He served 17 years previously with the Rhône-Poulenc group in the UK, France, Indonesia and Australia.
In 2010 Hugh co-founded DestiNA Genomics Ltd, a spin-out molecular diagnostic company from the University of Edinburgh, with R&D facilities in Granada Spain. He is a founder of a number of biotechnology companies in the UK, and a Joint-Venture in Japan. He works as a member of the Canadian National Centres of Excellence Standing Selection Committee, and acts as mentor to PhD students and post-docs at the University of Granada and University of Trento. He has dual British/Australian nationality, is bilingual in English/French, and lives in Scotland.